Epzicom abacavir/lamivudine: Phase IV data

The double-blind, U.S. Phase IV HEAT trial in 688 treatment-naïve patients with HIV showed that once-daily Epzicom met the primary endpoint of being comparable to once-daily Truvada emtricitabine/teno...